相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of ERK activity enhances the cytotoxic effect of peroxisome proliferator-activated receptor γ (PPARγ) agonists in HeLa cells
Ha Kyun Chang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds
Roberto Wuerth et al.
DRUG DISCOVERY TODAY (2016)
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
Katsuhiko Uesaka et al.
LANCET (2016)
Chemotherapy and Chemoprevention by Thiazolidinediones
Eleonore Froehlich et al.
BIOMED RESEARCH INTERNATIONAL (2015)
PPAR gamma gene - A review
C. Janani et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2015)
The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells
Giovanni Vitale et al.
BIOTECHNOLOGY ADVANCES (2012)
Cytotoxicity of troglitazone through PPARγ-independent pathway and p38 MAPK pathway in renal cell carcinoma
Megumi Fujita et al.
CANCER LETTERS (2011)
Specific Thiazolidinediones Inhibit Ovarian Cancer Cell Line Proliferation and Cause Cell Cycle Arrest in a PPARγ Independent Manner
Linah Al-Alem et al.
PLOS ONE (2011)
In vitro and in vivo therapeutic efficacy of the PPAR-γ agonist troglitazone in combination with cisplatin against malignant pleural mesothelioma cell growth
Naohiko Hamaguchi et al.
CANCER SCIENCE (2010)
PPARγ-independent antitumor effects of thiazolidinediones
Shuo Wei et al.
CANCER LETTERS (2009)
Proteasome inhibition overcomes the resistance of renal cell carcinoma cells against the PPARγ ligand troglitazone
K. von Schwarzenberg et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Loss of XIAP sensitizes colon cancer cells to PPARγ independent antitumor effects of troglitazone and 15-PGJ2
Liang Qiao et al.
CANCER LETTERS (2008)
JNK signaling in apoptosis
D. N. Dhanasekaran et al.
ONCOGENE (2008)
Thiazolidinediones modulate the expression of β-catenin and other cell-cycle regulatory proteins by targeting the F-Box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor γ
Shuo Wei et al.
MOLECULAR PHARMACOLOGY (2007)
Role of mitogen-activated protein kinase (MAPK) in troglitazone-induced osteoblastic cell death
Ju Young Jung et al.
TOXICOLOGY (2007)
Phorbol ester potentiates the growth inhibitory effects of troglitazone via up-regulation of PPARγ in A549 cells
Hyo Jung Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones
J-R Weng et al.
ENDOCRINE-RELATED CANCER (2006)
Involvement of MEK-ERK signaling pathway in the inhibition of cell growth by troglitazone in human pancreatic cancer cells
W Motomura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPAR-γ
CW Shiau et al.
CANCER RESEARCH (2005)
Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone -: Evidence for involvement of peroxisome proliferator-activated receptor (PPAR)γ-dependent and PPARγ-independent signaling pathways
DH Cho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Signaling pathways involved in induction of GADD45 gene expression and apoptosis by troglitazone in human MCF-7 breast carcinoma cells
F Yin et al.
ONCOGENE (2004)
Inhibition of cell invasion and morphological change by troglitazone in human pancreatic cancer cells
W Motomura et al.
JOURNAL OF GASTROENTEROLOGY (2004)
PPARγ ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21WAF1/Cip1 pathway
C Han et al.
HEPATOLOGY (2003)
Peroxisome proliferator-activated receptor γ ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines
K Yoshizawa et al.
CANCER (2002)
Troglitazone activates p21Cip/WAF1 through the ERK pathway in HCT15 human colorectal cancer cells
JA Kim et al.
CANCER LETTERS (2002)
Cytotoxicity and apoptosis produced by troglitazone in human hepatoma cells
Y Yamamoto et al.
LIFE SCIENCES (2001)
Ligands for peroxisome proliferator-activated receptor γ inhibit growth of pancreatic cancers both in vitro and in vivo
A Itami et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Lessons from the glitazones: a story of drug development
EAM Gale
LANCET (2001)
Activation of peroxisome proliferator-activated receptor gamma inhibits the growth of human pancreatic cancer
T Sasaki et al.
PATHOBIOLOGY (2001)
The PPARs: From orphan receptors to drug discovery
TM Willson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
